TEAS RF New Application

YESCARTA

Kite Pharma, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88351140
Filing Date: 03/21/2019

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88351140
MARK INFORMATION
*MARK \\TICRS\EXPORT17\IMAGEOUT 17\883\511\88351140\xml1\ RFA0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT YESCARTA
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) coral and purple is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of a stylized design of a tulip rotated 90 degrees to the left with a coral center and two purple leaves on either side, all to the left of the word YESCARTA in purple lettering.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 940 x 262
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Kite Pharma, Inc.
*STREET 2400 Broadway
*CITY Santa Monica
*STATE
(Required for U.S. applicants)
California
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
90404
PHONE 650-522-2401
FAX (650) 522-5575
EMAIL ADDRESS XXXX
WEBSITE ADDRESS www.gilead.com
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for immunotherapy, including cell therapy and gene therapy; biological preparations for the treatment of cancer
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 11/22/2017
       FIRST USE IN COMMERCE DATE At least as early as 11/22/2017
       SPECIMEN FILE NAME(S) \\TICRS\EXPORT17\IMAGEOUT 17\883\511\88351140\xml1\ RFA0003.JPG
       SPECIMEN DESCRIPTION Applicant's product displaying mark in use
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing medical and healthcare information; providing medical information in the field of pharmaceuticals and cell therapy
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 11/22/2017
       FIRST USE IN COMMERCE DATE At least as early as 11/22/2017
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-19215623611-20190321165237436248_._YESCARTA_Logo_Specimen_class_44.pdf
       CONVERTED PDF FILE(S)
       (2 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\511\88351140\xml1\RFA0004.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\511\88351140\xml1\RFA0005.JPG
       SPECIMEN DESCRIPTION Screenshot from Applicant's website displaying mark in use
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 5402449.
ATTORNEY INFORMATION
NAME Gretchen R. Stroud
FIRM NAME Gilead Sciences, Inc.
STREET 333 LAKESIDE DRIVE
CITY FOSTER CITY
STATE California
COUNTRY United States
ZIP/POSTAL CODE 94404
PHONE 650-522-2401
FAX (650) 522-5575
EMAIL ADDRESS trademarks@gilead.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Lori Mayall, Jack Wessel, Cynthia Smuzynska and Shelley Lai
CORRESPONDENCE INFORMATION
NAME Gretchen R. Stroud
FIRM NAME Gilead Sciences, Inc.
STREET 333 LAKESIDE DRIVE
CITY FOSTER CITY
STATE California
COUNTRY United States
ZIP/POSTAL CODE 94404
PHONE 650-522-2401
FAX (650) 522-5575
*EMAIL ADDRESS trademarks@gilead.com; trademarks@gilead.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 550
*TOTAL FEE PAID 550
SIGNATURE INFORMATION
SIGNATURE /Gretchen R. Stroud/
SIGNATORY'S NAME Gretchen R. Stroud
SIGNATORY'S POSITION Senior Associate General Counsel
SIGNATORY'S PHONE NUMBER 650-522-2401
DATE SIGNED 03/21/2019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88351140
Filing Date: 03/21/2019

To the Commissioner for Trademarks:

MARK: YESCARTA (stylized and/or with design, see mark)

The literal element of the mark consists of YESCARTA.
The color(s) coral and purple is/are claimed as a feature of the mark. The mark consists of a stylized design of a tulip rotated 90 degrees to the left with a coral center and two purple leaves on either side, all to the left of the word YESCARTA in purple lettering.
The applicant, Kite Pharma, Inc., a corporation of Delaware, having an address of
      2400 Broadway
      Santa Monica, California 90404
      United States
      650-522-2401(phone)
      (650) 522-5575(fax)
      XXXX (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for immunotherapy, including cell therapy and gene therapy; biological preparations for the treatment of cancer

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 11/22/2017, and first used in commerce at least as early as 11/22/2017, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Applicant's product displaying mark in use.
Specimen File1

       International Class 044:  Providing medical and healthcare information; providing medical information in the field of pharmaceuticals and cell therapy

In International Class 044, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 11/22/2017, and first used in commerce at least as early as 11/22/2017, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Screenshot from Applicant's website displaying mark in use.

Original PDF file:
SPE0-19215623611-20190321165237436248_._YESCARTA_Logo_Specimen_class_44.pdf
Converted PDF file(s) (2 pages)
Specimen File1
Specimen File2



Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 5402449.

For informational purposes only, applicant's website address is: www.gilead.com

The applicant's current Attorney Information:
      Gretchen R. Stroud and Lori Mayall, Jack Wessel, Cynthia Smuzynska and Shelley Lai of Gilead Sciences, Inc.      333 LAKESIDE DRIVE
      FOSTER CITY, California 94404
      United States
      650-522-2401(phone)
      (650) 522-5575(fax)
      trademarks@gilead.com (authorized)


The applicant's current Correspondence Information:
      Gretchen R. Stroud
      Gilead Sciences, Inc.
      333 LAKESIDE DRIVE
      FOSTER CITY, California 94404
      650-522-2401(phone)
      (650) 522-5575(fax)
      trademarks@gilead.com;trademarks@gilead.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Gretchen R. Stroud/   Date: 03/21/2019
Signatory's Name: Gretchen R. Stroud
Signatory's Position: Senior Associate General Counsel
Payment Sale Number: 88351140
Payment Accounting Date: 03/22/2019

Serial Number: 88351140
Internet Transmission Date: Thu Mar 21 18:57:25 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-201903211857252
95837-88351140-620431e8e1e42e1ade13a8149
a1aea3a61fe6264b1629826a3292b5eaa4c947e9
7-DA-5850-20190321165237436248

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed